Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Sarcoidosis Clinical Trials
Sarcoidosis clinical trials are recruiting across 38 cities. Here are the cities with the most active studies:
Sarcoidosis Trial Phases
14 research organizations are sponsoring sarcoidosis trials.
About Sarcoidosis
Sarcoidosis is an inflammatory disease characterized by the formation of granulomas (clumps of inflammatory cells) in various organs, most commonly the lungs and lymph nodes. Many cases resolve on their own, but some require treatment with corticosteroids or immunosuppressive medications.
Clinical trials are advancing new treatments for sarcoidosis. Currently, 20 studies are recruiting a combined 38,516 participants across the United States. Research is being conducted by 14 organizations including Duke University, Foundation for Sarcoidosis Research, National Institute of Allergy and Infectious Diseases (NIAID) and 11 others.
2026 Sarcoidosis Research Landscape
As of July 2026, the sarcoidosis clinical trial landscape includes 20 actively recruiting studies across 38 cities in the United States. These studies are collectively seeking 38,516 participants, with an average enrollment target of 1,926 per study.
The research spans multiple phases of development: 9 studies are in PHASE2, 6 studies are in PHASE1, 2 studies are in NA, 1 study is in PHASE3, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some sarcoidosis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 14 different organizations, including Duke University, Foundation for Sarcoidosis Research, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, Ottawa Heart Institute Research Corporation, and 9 others. The large number of sponsors reflects significant research interest and investment in sarcoidosis treatment advancement.
Geographically, sarcoidosis trials are most concentrated in Bethesda, Maryland (5 trials); Durham, North Carolina (4 trials); Baltimore, Maryland (4 trials); New York, New York (3 trials); Philadelphia, Pennsylvania (3 trials) and 7 other cities.
Featured Sarcoidosis Studies
Highlighted recruiting studies for sarcoidosis, selected by enrollment size and research scope.
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patients can also link their Electronic Health Records (EHR). The goal is to create a natural history of s...
Evaluation of Patients With Immune Function Abnormalities
This study will evaluate patients with abnormal immune function that results in recurrent or unusual infections or chronic inflammation. This may include inherited conditions, such as X-linked severe combined immunodeficiency (XSCID), chronic granulomatous disease (CGD), and leukocyte adhesion deficiency (LAD), or conditions resulting from outside factors, such as graft-versus-host disease (GVHD)....
Frequently Asked Questions About Sarcoidosis Clinical Trials
Are there sarcoidosis clinical trials near me?
Yes, there are 20 sarcoidosis clinical trials currently recruiting across 38+ cities in the United States, including Bethesda, Maryland; Durham, North Carolina; Baltimore, Maryland. Browse the studies above to find one at a location convenient for you.
How do I join a sarcoidosis clinical trial?
To join a sarcoidosis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are sarcoidosis clinical trials free?
Yes, participation in sarcoidosis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of sarcoidosis treatments are being studied?
Current sarcoidosis clinical trials are testing a range of approaches across PHASE2 (9 studies), PHASE1 (6 studies), NA (2 studies), PHASE3 (1 study), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.
Is it safe to participate in sarcoidosis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov